title: Review of topiramate for the treatment of epilepsy in elderly patients.
abstract: Individuals over 65 years of age experience the new onset of seizures at a prevalence rate of roughly twice that of younger adults. Differences in physiology, need of concomitant medications, and liability for cognitive deficits in this population, make the choice of anticonvulsant drugs especially important. This paper reviews topiramate (TPM), a treatment for many types of seizures, with the above risks in mind. In particular, we discuss efficacy and pharmacokinetics with emphasis on the older patient, and adverse events in both the younger and older adult. With most studies of TPM-induced cognitive deficits having been performed in younger adults and volunteers, we discuss the implications for the older adult. Even in studies of younger individuals, up to 50% discontinue TPM because of intolerable cognitive deficits. Most studies find specific declines in working memory and verbal fluency. In conclusion, we give recommendations for use of this antiepileptic drug in this population.
authors.affiliation: Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305-5723, USA. brsommer@stanford.edu
authors.forename: B R
authors.initials: BR
authors.lastname: Sommer
authors.forename: H H
authors.initials: HH
authors.lastname: Fenn
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004827:Epilepsy / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D005632:Fructose / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008875:Middle Aged; D000077236:Topiramate; D055815:Young Adult
chemical_list: D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose
references.citation: Seizure. 2005 Sep;14(6):371-80
references.pmid: 15961326
references.citation: CNS Neurosci Ther. 2008 Summer;14(2):120-42
references.pmid: 18482025
references.citation: Epilepsia. 1993 May-Jun;34(3):453-68
references.pmid: 8504780
references.citation: Ann Clin Psychiatry. 2001 Dec;13(4):185-9
references.pmid: 11958360
references.citation: Neurology. 2003 May 13;60(9):1483-8
references.pmid: 12743236
references.citation: Clin Neuropharmacol. 2001 Sep-Oct;24(5):284-9
references.pmid: 11586113
references.citation: Neurology. 1996 Jun;46(6):1678-83
references.pmid: 8649569
references.citation: Drugs. 1997 Nov;54(5):752-73
references.pmid: 9360061
references.citation: Epilepsia. 2000;41(S1):77-81
references.pmid: 10768306
references.citation: Epilepsia. 2000;41(S1):3-9
references.pmid: 10768292
references.citation: Epilepsia. 1999 Dec;40(12):1767-74
references.pmid: 10612342
references.citation: Neurology. 1996 Jun;46(6):1684-90
references.pmid: 8649570
references.citation: Epilepsy Behav. 2006 Jun;8(4):736-41
references.pmid: 16647301
references.citation: Epilepsia. 1996 Oct;37(10):951-5
references.pmid: 8822693
references.citation: Acta Neurol Scand. 2003 Mar;107(3):165-75
references.pmid: 12614309
references.citation: Drug Saf. 2007;30(7):555-67
references.pmid: 17604407
references.citation: Epilepsia. 2003 May;44(5):659-63
references.pmid: 12752464
references.citation: Arch Neurol. 2008 Nov;65(11):1467-71
references.pmid: 19001165
references.citation: Exp Gerontol. 2003 Aug;38(8):843-53
references.pmid: 12915206
references.citation: Clin Geriatr Med. 1988 Feb;4(1):127-49
references.pmid: 3278786
references.citation: Neurology. 2004 Mar 9;62(5 Suppl 2):S24-9
references.pmid: 15007161
references.citation: Ann Clin Biochem. 2004 Mar;41(Pt 2):166-9
references.pmid: 15025812
references.citation: J Affect Disord. 2005 Aug;87(2-3):243-52
references.pmid: 15985295
references.citation: J Anal Toxicol. 2006 Oct;30(8):599-602
references.pmid: 17132258
references.citation: Expert Opin Drug Saf. 2007 Sep;6(5):547-57
references.pmid: 17877442
references.citation: J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):44-50
references.pmid: 10369821
references.citation: Clin Pharmacokinet. 2004;43(12):763-80
references.pmid: 15355124
references.citation: Acad Emerg Med. 2009 Mar;16(3):193-200
references.pmid: 19154565
references.citation: Drug Saf. 2001;24(13):991-1015
references.pmid: 11735655
references.citation: Neurology. 2004 Aug 24;63(4):762; author reply 762
references.pmid: 15326274
references.citation: Seizure. 2002 Jun;11(4):255-60
references.pmid: 12027573
references.citation: Neurology. 2003 Jan 28;60(2):196-202
references.pmid: 12552030
references.citation: Lancet. 2000 Apr 22;355(9213):1441-6
references.pmid: 10791538
references.citation: Clin Ther. 1997 Nov-Dec;19(6):1294-308
references.pmid: 9444441
references.citation: J Clin Neurol. 2006 Jun;2(2):126-33
references.pmid: 20396496
references.citation: Epilepsia. 1996;37 Suppl 2:S18-S22
references.pmid: 8641242
references.citation: Neurology. 2005 Jun 28;64(12):2108-14
references.pmid: 15985582
references.citation: Acta Neurol Scand. 2008 Sep;118(3):164-74
references.pmid: 18384458
references.citation: Clin Pharmacokinet. 2006;45(11):1061-75
references.pmid: 17048972
references.citation: Am J Kidney Dis. 2006 Oct;48(4):555-63
references.pmid: 16997051
references.citation: Arch Neurol. 2000 Dec;57(12):1727-31
references.pmid: 11115238
references.citation: J Psychosom Res. 2008 Sep;65(3):249-54
references.pmid: 18707947
references.citation: Epilepsy Behav. 2006 Feb;8(1):161-8
references.pmid: 16266829
references.citation: Epilepsia. 2008 Jul;49(7):1180-5
references.pmid: 18494791
references.citation: Epilepsia. 2000;41(S1):66-71
references.pmid: 10768304
references.citation: Epilepsia. 2000;41(S1):35-9
references.pmid: 10768298
references.citation: Epilepsia. 1996 Aug;37(8):763-8
references.pmid: 8764816
references.citation: Neurology. 2006 Aug 8;67(3):400-6
references.pmid: 16894098
references.citation: Epilepsia. 1996 Mar;37(3):224-9
references.pmid: 8598179
references.citation: Psychosomatics. 2005 Jul-Aug;46(4):302-16
references.pmid: 16000673
references.citation: Epilepsia. 2005 Feb;46(2):298-303
references.pmid: 15679511
references.citation: Pain Med. 2008 Mar;9(2):175-85
references.pmid: 18298700
references.citation: Epilepsy Behav. 2005 May;6(3):373-81
references.pmid: 15820346
references.citation: Epilepsia. 2008 Jul;49(7):1239-76
references.pmid: 18397299
references.citation: Epilepsia. 2001 Sep;42(9):1134-40
references.pmid: 11580760
references.citation: Acta Neurol Scand Suppl. 2005;181:40-6
references.pmid: 16238708
references.citation: Epilepsy Behav. 2006 Feb;8(1):181-91
references.pmid: 16377253
references.citation: Epilepsy Behav. 2009 Mar;14(3):556-9
references.pmid: 19150415
references.citation: Epilepsy Res. 2006 Jan;68 Suppl 1:S49-63
references.pmid: 16207524
references.citation: Epilepsia. 1997 Mar;38(3):294-300
references.pmid: 9070591
references.citation: Drug Saf. 2007;30(2):123-42
references.pmid: 17253878
references.citation: Epilepsia. 2000 Sep;41(9):1167-78
references.pmid: 10999556
references.citation: Epilepsy Behav. 2004 Oct;5(5):716-21
references.pmid: 15380124
references.citation: J Clin Pharmacol. 1996 Oct;36(10):884-91
references.pmid: 8930774
references.citation: Epilepsia. 2002 Apr;43(4):365-85
references.pmid: 11952767
references.citation: Epilepsia. 2005 Mar;46(3):378-84
references.pmid: 15730535
references.citation: Lancet. 2000 Apr 15;355(9212):1315-9
references.pmid: 10776744
references.citation: Arch Ophthalmol. 2002 Aug;120(8):1108
references.pmid: 12149075
references.citation: Neurology. 2005 Mar 8;64(5):792-8
references.pmid: 15753411
references.citation: Acta Neurol Scand. 2005 Sep;112(3):144-50
references.pmid: 16097955
references.citation: Lancet. 2007 Mar 24;369(9566):1016-26
references.pmid: 17382828
references.citation: Neurologist. 2003 Sep;9(5):241-9
references.pmid: 12971835
references.citation: Epilepsy Behav. 2003 Oct;4 Suppl 2:S25-38
references.pmid: 14527481
references.citation: Acta Neurol Scand. 2005 Oct;112(4):214-22
references.pmid: 16146489
references.citation: Ann Pharmacother. 2005 Nov;39(11):1852-60
references.pmid: 16189285
references.citation: Neurology. 2007 Oct 23;69(17):1657-64
references.pmid: 17954781
references.citation: Lancet. 2000 Oct 7;356(9237):1255-9
references.pmid: 11072960
references.citation: Epilepsia. 1996 Jun;37(6):539-43
references.pmid: 8641230
references.citation: Epilepsy Res. 2003 May;54(2-3):171-8
references.pmid: 12837568
references.citation: Epilepsy Res. 1996 Nov;25(3):217-24
references.pmid: 8956919
references.citation: Neurology. 2003 Nov 11;61(9):1306
references.pmid: 14610152
references.citation: Epilepsy Res. 2008 Feb;78(2-3):140-6
references.pmid: 18155445
references.citation: Seizure. 2008 Jan;17(1):19-26
references.pmid: 17618131
references.citation: Epilepsia. 2002 Jul;43(7):691-6
references.pmid: 12102670
references.citation: Drug Saf. 2001;24(7):513-36
references.pmid: 11444724
references.citation: Drugs Aging. 1999 Oct;15(4):255-69
references.pmid: 10582773